Saudi Arabia Animal Biotechnology Market By Product (Diagnostics, Biologics, Drugs, Nutrition, Others), By Animal Type (Dogs, Cats, Horses, Poultry, Swine, Cattle, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

Saudi Arabia Animal Biotechnology Market was valued at USD 75.84 Million in 2024 and is expected to reach USD 92.16 Million by 2030 with a CAGR of 3.50% during the forecast period.

The Saudi Arabia Animal Biotechnology Market is experiencing significant growth, driven by increasing demand for innovative solutions in the agricultural and veterinary sectors. Animal biotechnology, which involves the application of scientific and technological advancements to improve livestock health, breeding, and productivity, is gaining traction in the country due to its potential to enhance food security and sustainability.

A key factor contributing to the expansion of the market is the rising need for advanced biotechnological tools to address challenges such as disease outbreaks and the need for efficient livestock management. Genetic engineering, molecular diagnostics, and reproductive technologies are some of the prominent innovations transforming the industry. These technologies allow for the development of healthier and more resilient animals, reducing the risk of disease transmission and improving overall livestock performance.

As the market continues to evolve, it presents numerous opportunities for companies involved in animal biotechnology to introduce innovative products and services that address the specific needs of the Saudi livestock industry. Collaborations between local and international stakeholders are expected to further enhance the development and adoption of cutting-edge biotechnological solutions, positioning Saudi Arabia as a key player in the global animal biotechnology landscape.

Key Market Drivers

Growth in Healthcare Industry

The expansion of Saudi Arabia’s healthcare industry is a key driver for the animal biotechnology market. The Healthcare Sector Transformation Program is restructuring the system to be more integrated, efficient, and innovative. It focuses on disease prevention, financial sustainability, and improved access to care, supported by plans to recruit 175,000 healthcare professionals by 2030. Digital health solutions, enhanced quality standards, and compliance with international benchmarks are integral to this transformation. The rising demand for advanced therapeutic solutions and innovation in healthcare is fueling the adoption of animal biotechnology in the Kingdom.

Animal biotechnology is crucial for producing vaccines, therapeutic proteins, and diagnostic tools. These innovations rely on animal models and are increasingly applied in healthcare research and development. The emergence of zoonotic diseases has highlighted the need for more effective vaccines. Rabies, an almost universally fatal zoonotic disease, remains endemic among animals in Saudi Arabia. Data from the Al-Qassim region show 63 of 158 confirmed animal rabies cases in the Kingdom between 2010 and 2017 were camels, illustrating the ongoing need for advanced biotechnological interventions.

These developments align with Vision 2030, which promotes economic diversification and local production of advanced medical technologies. The National Biotechnology Strategy, part of Vision 2030, targets positioning Saudi Arabia as a global biotech hub by 2040. The initiative is expected to contribute $34.6 billion to non-oil GDP and create 11,000 jobs by 2030, supporting both the healthcare and biotechnology sectors.

Surge in Technological Advancements

Technological advancements are a key driver of Saudi Arabia’s animal biotechnology market. As the Kingdom diversifies its economy and strengthens its agricultural and livestock sectors, advanced technologies are being applied to improve animal health and optimize production. In March 2022, KAUST partnered with the Ministry of Environment, Water, and Agriculture (MEWA) to launch the “Development of Algal Biotechnology in the Kingdom of Saudi Arabia” (DABKSA) initiative. The project focuses on producing sustainable animal feed, starting with a pilot facility of 870 m² and scaling up to 42,000 m², with an annual target of 100 tons of algae dry biomass. The initiative is overseen by MEWA’s National Fisheries Development Program and hosted at KAUST, aiming to strengthen feed production and enhance livestock sustainability.

Genetic engineering, molecular diagnostics, and reproductive technologies have enabled the development of improved animal breeds with greater disease resistance, productivity, and adaptability to Saudi Arabia’s climate. Animal genomics and precision farming technologies are providing farmers with data-driven insights into animal behavior, health, and performance, reducing costs and improving management. For example, 15 livestock and bioinformatics specialists from MEWA, NLFDP, and King Saud University completed a 12-week course on genomic selection and modern breeding strategies, highlighting the sector’s focus on capacity building.

Integration of AI and IoT technologies is further transforming operations. Tools like the "SMART FLOCK SAUDI" mobile app allow small ruminant farms, managing 200–500 animals, to track activity and monitor health in real time. This approach enhances animal welfare, reduces dependence on antibiotics, and supports sustainable livestock management, strengthening the Kingdom’s animal biotechnology sector.

Download Free Sample Report

Key Market Challenges

Lack of Skilled Workforce

A significant challenge facing the animal biotechnology market in Saudi Arabia is the lack of a skilled workforce. As the industry evolves with advanced technologies and innovative practices, there is a growing demand for specialized professionals with expertise in areas such as genetic engineering, molecular biology, and bioinformatics. However, the current talent pool in the Kingdom is limited, creating a skills gap that hinders the industry's growth.

This shortage of qualified professionals impacts both the development and implementation of cutting-edge biotechnology solutions. Companies may struggle to find the expertise needed to drive innovation, research, and product development, slowing the progress of critical projects. Additionally, the need for a robust skilled workforce can lead to an increased reliance on international talent, which may inflate operational costs and create dependency on external resources.

Key Market Trends

Increased Focus on Animal Health and Disease Prevention

The rising focus on animal health and disease prevention has become a significant trend driving the growth of Saudi Arabia’s animal biotechnology market. As the country continues to develop its agricultural and livestock sectors, there is an increasing recognition of the need to improve animal health, productivity, and welfare. This shift is being fueled by both government initiatives and growing private sector investments aimed at safeguarding animal populations and ensuring the sustainability of food production.

Rabies virus is regarded as an endemic viral infectious disease among animals in Saudi Arabia. Recent scientific data on rabies cases reported in camels from the Al-Qassim region (one of the thirteen administrative regions of Saudi Arabia) indicate a concerning rise in the number of cases of this fatal viral disease. One of the key factors contributing to this trend is the growing awareness of the economic impact of animal diseases. Outbreaks of infectious diseases in livestock can lead to significant financial losses due to decreased productivity, increased veterinary costs, and trade restrictions. As a result, there is a heightened demand for biotechnological solutions such as advanced vaccines, diagnostics, and genetic technologies that can prevent the spread of diseases and improve the overall health of animal populations.

Segmental Insights

Product Insights

Based on Product, Diagnostics have emerged as the fastest growing segment in the Saudi Arabia Animal Biotechnology Market in 2024. One of the primary drivers is the increasing demand for advanced diagnostic tools to ensure animal health and prevent the spread of diseases. As the livestock and aquaculture sectors expand in response to rising food security needs, the importance of early and accurate detection of diseases has become paramount. Additionally, the growing focus on improving livestock productivity has further fueled the demand for diagnostics. With enhanced diagnostics, farmers and veterinarians can make informed decisions on disease management, resulting in better animal health outcomes and higher yields.

Animal Type Insights

Based on Animal Type, Dogs have emerged as the fastest growing segment in the Saudi Arabia Animal Biotechnology Market during the forecast period. One of the primary drivers is the growing pet ownership trend in Saudi Arabia, particularly in urban areas where dogs are becoming increasingly popular as companions. As more households, particularly among the younger and expatriate populations, adopt dogs, there is rising demand for advanced healthcare solutions, including biotechnology-based products such as vaccines, diagnostics, and treatments for common canine diseases. This has fueled growth in the biotechnology sector, with a focus on enhancing the health and welfare of dogs.

Download Free Sample Report

Regional Insights

Based on Region, Northern & Central have emerged as the dominating region in the Saudi Arabia Animal Biotechnology Market in 2024. The Northern and Central regions are home to some of the largest agricultural and livestock operations in Saudi Arabia. These areas are crucial for livestock farming, which is a significant contributor to the country's agriculture sector. As a result, there is a high demand for advanced biotechnology solutions to enhance animal health, productivity, and breeding practices in these regions. Key research institutions and universities focused on biotechnology are located in these regions. These institutions are driving advancements in animal genomics, vaccine development, and genetic engineering, making Northern and Central Saudi Arabia the epicenters of innovation and research in the field of animal biotechnology.

Recent Development

• In August 2025, First Milling Co. acquired Al-Manar Feed Co. LLC, an animal feed production plant in Jeddah. The acquisition increases First Milling's daily feed production by 450 tons, raising total capacity to 1,350 tons per day.
• In July 2025, the Ministry of Environment, Water and Agriculture (MEWA) launched multiple AI-driven platforms, including the AI Platform for Animal Health, which was recognised at the World Summit on the Information Society (WSIS) 2025 for its impact.
• In February 2025, at the LEAP 2025 conference, the Deputy Minister of Environment launched the Artificial Intelligence Platform for Animal Health. The system uses AI to analyse veterinary data, predict animal disease cases, and provide insights on veterinary visits, infections, and fatalities, improving veterinary care and service efficiency.
• In 2025, Japan's SBI Holdings plans to launch its first biotechnology-focused investment fund in Saudi Arabia. In partnership with the Ministry of Investment and co-managed with Saudi-based BIM Ventures, the fund will manage $50–100 million to support the domestic biotech industry.
• In November 2024, the SMART FLOCK SAUDI mobile application was introduced to support small ruminant farming using IoT technology. Developed with MEWA, the app enhances farm management, productivity, and animal welfare through real-time monitoring and data analytics.
• In 2024 Saudi Arabia launched a national biotech strategy aimed at becoming a global biotech hub over the next 16 years. This initiative is part of Vision 2030, focusing on vaccine development, advanced manufacturing, and local bio-manufacturing platforms. Strengthening the biotech sector is expected to increase domestic production, create jobs, and drive economic diversification.
• In 2024, A Saudi delegation from MEWA explored collaboration with BIOTEC to advance aquaculture and livestock innovations. Potential projects include vaccine development, microbiome research, and the use of biofilm inhibitors and probiotics to prevent bacterial diseases in aquatic species. MEWA’s National Aquaculture Group (NAQUA) is already working with BIOTEC on a joint breeding program to develop shrimp stocks tolerant to white spot syndrome virus.

Key Market Players

• Saudi MAS Veterinary Services Company
• Biogénesis Bagó S.A.
• ALEMAR International
• Animal Nation KSA
• MONTAJAT VETERINARY PHARMACEUTICALS CO. LTD

Report Scope

In this report, the Saudi Arabia Animal Biotechnology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Saudi Arabia Animal Biotechnology Market, By Product:

o   Diagnostics

o   Biologics

o   Drugs

o   Nutrition

o   Others

• Saudi Arabia Animal Biotechnology Market, By Animal Type:

o   Dogs

o   Cats

o   Horses

o   Poultry

o   Swine

o   Cattle

o   Others

• Saudi Arabia Animal Biotechnology Market, By Region:

o   Eastern

o   Western

o   Northern & Central

o   Southern

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Saudi Arabia Animal Biotechnology Market.

Available Customizations:

Saudi Arabia Animal Biotechnology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Saudi Arabia Animal Biotechnology Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]